SUCCESS AND SAFETY OF MISOPROSTOL FOR TREATMENT OF EARLY PREGNANCY FAILURE
Abstract
Background: Early pregnancy failure is a common complication in pregnancies. It can be managed medically as well as surgically. Lately there has been an emphasis on medical management of early pregnancy failure. Misoprostol, a Prostaglandin E1 analogue has been found to be safe and effective in treatment of early pregnancy failure. Methods: This was a descriptive cross-sectional study that was conducted at the department of gynaecology and obstetrics, Ayub teaching hospital Abbottabad from Jan 2015 to Dec 2016. A total of 81 pregnant women with early pregnancy failure were enrolled in the study. Misoprostol was administered in a dose of 800 µg PO and repeated every 3 hours for a maximum of three doses if and when required. Results: Misoprostol was effective in 60 (74.07%) patients and it resulted in complete expulsion of products of conception. The remainder needed surgical evacuation. There was a low incidence of side effects with nausea being the most common (4.94%) followed by PV bleeding (3.70%), abdominal cramps (3.70%) and diarrhoea (2.47%). Conclusion: Misoprostol is a safe and effective treatment option for the management of early pregnancy failure.Keywords: Abortion; Pregnancy failure; MisoprostolReferences
Zhang J, Gilles JM, Barnhart K, Creinin MD, Westhoff C, Frederick MM, et al. A Comparison of Medical Management with Misoprostol and Surgical Management for Early Pregnancy Failure. N Engl J Med 2005;353(8):761–9.
Gariepy AM, Stanwood NL. Medical management of early pregnancy failure. 2013. [Internet]. Contemporary OB/GYN 2013 [cited 2017 Dec 6]. Available from: http://contemporaryobgyn.modernmedicine.com/contemporary-obgyn/content/tags/early-pregnancy-failure/medical-management-early-pregnancy-failure
Chen BA, Creinin MD. Medical management of early pregnancy failure: efficacy. Semin Reprod Med 2008;26(5):411–22.
Creinin MD, Schwartz JL, Guido RS, Pymar HC. Early pregnancy failure-current management concepts. Obstet Gynecol Surv 2001;56(2):105–13.
Rouzi AA, Almansouri N, Sahly N, Alsenani N, Abed H, Darhouse K, et al. Efficacy of intra-cervical misoprostol in the management of early pregnancy failure. Sci Rep 2014;4:7182.
Induced abortion operations and their early sequelae. Joint study of the Royal College of General Practitioners and the Royal College of Obstetricians and Gynaecologists. J R Coll Gen Pract 1985;35(273):175–80.
Wu HL, Marwah S, Wang P, Wang QM, Chen XM. Misoprostol for medical treatment of missed abortion: a systematic review and network meta-analysis. Sci Rep 2017;7(1):1664.
Chia KV, Ogbo VI. Medical termination of missed abortion. J Obstet Gynaecol 2002;22(2):184–6.
Petrou S, Trinder J, Brocklehurst P, Smith L. Economic evaluation of alternative management methods of first-trimester miscarriage based on results from the MIST trial. BJOG 2006;113(8):879–89.
American College of Obstetricians and Gynecologists. Practice bulletin no. 143: medical management of first-trimester abortion. Obstet Gynecol 2014;123(3):676–92.
WHO. Safe abortion: technical and policy guidance for health systems. 2nd ed. Geneva: World Health Organization, 2012; p.132.
Watkinson G, Hopkins A, Akbar FA. The therapeutic efficacy of misoprostol in peptic ulcer disease. Postgrad Med J 1988;64(Suppl 1):60–77.
Sharma D, Singhal SR, Rani XX. Sublingual misoprostol in management of missed abortion in India. Trop Doct 2007;37(1):39–40.
Seyam Y, Flamerzi M, Abdallah M, Ahmed B. Vaginal misoprostol in the management of first trimester non-viable pregnancy. Qatar Med J 2008;2008(1):9.
Tasneem S, Gul MS, Navid S, Alam K. Efficacy and safety of misoprostol in missed miscarriage in terms of blood loss. Rawal Med J 2014;39(3):314–8.
Poveda C, Ruiz E, Campos Z, De Leon R, Grajales B, Moreno C. Intrauterine misoprostol: a new high effective treatment of missed abortion. Fertil Steril 2001;76(3):S96.
FIGO. Misoprostol Recommended Dosages 2012. [Internet]. International Federation of Gynecology and Obstetrics. 2012 [cited 2017 Dec 7]. Available from: https://www.figo.org/sites/default/files/uploads/project-publications/Miso/Misoprostol_Recommended%20Dosages%202012.pdf
NICE. Medical management of incomplete or missed miscarriage - NICE Pathways [Internet]. National Institute for Health and Care Excellence 2014 [cited 2017 Dec 7]. Available from: https://pathways.nice.org.uk/pathways/ectopic-pregnancy-and-miscarriage#path=view%3A/pathways/ectopic-pregnancy-and-miscarriage/medical-management-of-incomplete-or-missed-miscarriage.xml&content=view-index
Tang OS, Gemzell-Danielsson K, Ho PC. Misoprostol: pharmacokinetic profiles, effects on the uterus and side-effects. Int J Gynaecol Obstet 2007;99(Suppl 2):S160–7.
Rouzi AA, Alsibiani S, Mansouri N, Alsinani N, Darhouse K. Randomized clinical trial between hourly titrated oral misoprostol and vaginal dinoprostone for induction of labor. Am J Obstet Gynecol 2014;210(1):56.e1–6.
Creinin MD, Huang X, Westhoff C, Barnhart K, Gilles JM, Zhang J, et al. Factors Related to Successful Misoprostol Treatment for Early Pregnancy Failure: Obstet Gynecol 2006;107(4):901–7.
Benchamanon R, Phupong V. Effectiveness of a single dose of oral misoprostol 600 μg for treatment in early pregnancy failure. J Obstet Gynaecol 2014;34(8):726–9.
Mizrachi Y, Dekalo A, Gluck O, Miremberg H, Dafna L, Feldstein O, et al. Single versus repeat doses of misoprostol for treatment of early pregnancy loss–a randomized clinical trial. Hum Reprod 2017;32(6):1202–7.
Seervi N, Hooja N, Rajoria L, Verma A, Malviya K, Mehta N. Comparison of different regimes of misoprostol for the termination of early pregnancy failure. Med J Armed Forces India 2014;70(4):360–3.
Fernlund A, Jokubkiene L, Sladkevicius P, Valentin L. Misoprostol treatment vs expectant management in women with early non-viable pregnancy and vaginal bleeding: a pragmatic randomized controlled trial. Ultrasound Obstet Gynecol 2018;51(1):24–32.
Bracken H, Ngoc NT, Banks E, Blumenthal PD, Derman RJ, Patel A, et al. Buccal misoprostol for treatment of fetal death at 14–28 weeks of pregnancy: a double-blind randomized controlled trial. Contraception 2014;89(3):187–92.
Rizwan N, Uddin SF. Medical treatment of the complication of first trimester pregnancy loss with misoprostol. Int J Med Med Sci 2014;6(9):211–4.
Niang MM, Augowet NAF, Diallo D, Thiam M, Moreau JC, Cisse CT, et al. The use of misoprostol in outpatient treatment of abortions in the first quarter of pregnancy in Dakar. Int J Reprod Contracept Obstet Gynecol 2017;6(11):4782–5.
Published
Issue
Section
License
Journal of Ayub Medical College, Abbottabad is an OPEN ACCESS JOURNAL which means that all content is FREELY available without charge to all users whether registered with the journal or not. The work published by J Ayub Med Coll Abbottabad is licensed and distributed under the creative commons License CC BY ND Attribution-NoDerivs. Material printed in this journal is OPEN to access, and are FREE for use in academic and research work with proper citation. J Ayub Med Coll Abbottabad accepts only original material for publication with the understanding that except for abstracts, no part of the data has been published or will be submitted for publication elsewhere before appearing in J Ayub Med Coll Abbottabad. The Editorial Board of J Ayub Med Coll Abbottabad makes every effort to ensure the accuracy and authenticity of material printed in J Ayub Med Coll Abbottabad. However, conclusions and statements expressed are views of the authors and do not reflect the opinion/policy of J Ayub Med Coll Abbottabad or the Editorial Board.
USERS are allowed to read, download, copy, distribute, print, search, or link to the full texts of the articles, or use them for any other lawful purpose, without asking prior permission from the publisher or the author. This is in accordance with the BOAI definition of open access.
AUTHORS retain the rights of free downloading/unlimited e-print of full text and sharing/disseminating the article without any restriction, by any means including twitter, scholarly collaboration networks such as ResearchGate, Academia.eu, and social media sites such as Twitter, LinkedIn, Google Scholar and any other professional or academic networking site.
